John D. Schneible Ph.D.

Patent Agent

2100 Pennsylvania Avenue NW
Suite 350S
Washington, District of Columbia 20037


John is a patent agent supporting the Intellectual Property and Litigation & Dipsute Resolution practices, as well as the Dietary Supplements industry team.

John focuses primarily on prosecuting intellectual by assisting companies ranging in size from start-ups to Fortune 500 companies. John works with companies across a variety of sectors, including genetic technologies, biological therapeutic and diagnostic molecules, pharmaceuticals, dietary supplements, and other consumer products.

Prior to joining AGG, John served as a patent examiner with the USPTO, examining applications related to steel articles, copper-based foils, and metal/glass coatings. John has a Ph.D. in chemical engineering and has authored over 10 peer-reviewed publications on drug delivery platforms and biologic purification technologies.


  • North Carolina State University, Doctor of Philosophy - Chemical Engineering
    • GAANN Teaching Fellow
    • Provost’s Doctoral Fellow
  • State University of New York at Buffalo, Bachelor of Science - Chemical Engineering,
    summa cum laude
    • Tau Beta Pi
  • United States Patent and Trademark Office
    • American Chemical Society
    • Alpha Phi Omega


  • “Chitosan: A Versatile Bio-platform for Breast Cancer Theranostics,” Journal of Control Release, December 2021
  • “Engineering Next Generation Cyclized Peptide Ligands for Light-controlled Capture and Release of Therapeutic Proteins,” Advance Functional Materials, May 2021
  • “Synthetic Platelet Microgels Containing Fibrin Knob B Mimetic Motifs Enhance Clotting Responses,” Advanced Therapeutics, March 2021
  • “Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands,” International Journal of Molecular Sciences, February 2021
  • “Natural and Synthetic Biopolymers in Drug Delivery and Tissue Engineering,” Chapter 9 in Biopolymers for Biomedical and Biotechnological Applications, November 2020
  • “A Multiscale Coarse-Grained Model to Predict the Molecular Architecture and Drug Transport Properties of Modified Chitosan Hydrogels,” Soft Matter, October 2020
  • “Peptides and Pseudopeptide Ligands: A Powerful Toolbox for the Affinity Purification of Current and Next-Generation Biotherapeutics,” Journal of Chromatography A, October 2020
  • “Chitosan Hydrogels for Synergistic Delivery of Chemotherapeutics to Triple Negative Breast Cancer Cells and Spheroids,” Pharmaceutical Research, July 2020
  • “Photoinduced Reconfiguration to Control the Protein-Binding Affinity of Azobenzene-Cyclized Peptides,” Journal of Materials Chemistry B, June 2020
  • “Modified Graphene Oxide (GO) Particles in Peptide Hydrogels: a Hybrid System Enabling Scheduled Delivery of Synergistic Combinations of Chemotherapeutics,” Journal of Materials Chemistry B, March 2020
  • “Tailoring the Chemical Modification of Chitosan Hydrogels to Fine-Tune the Release of a Synergistic Combination of Chemotherapeutics,” ACS Biomacromolecules, July 2019